This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Marie-France Poirier-Littre, MD; Henri Loo, MD
Service Hospitalo Universitaire de Santé Mentale Hôpital Sainte-Anne 1 Rue Cabanis 75674 Paris Cedex, France

Trevor Dennis, PhD; Bernard Scatton, MD, PhD
Bagneux, France

Arch Gen Psychiatry. 1993;50(1):72-73.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Manji and associates¹ reported that 2 weeks of treatment with lithium enhanced norepinephrine (NE) levels in plasma and urinary NE and normetanephrine (NMN) excretion in normal subjects, while 1 week of treatment with lithium did not. These temporally specific effects of lithium treatment on NE turnover have been suggested to be connected to desensitization of presynaptic-2— adrenergic receptors in peripheral sympathetic nerves.

We confirm these results and spec

ify the temporal action of lithium salts on plasma NE turnover. Our study in healthy volunteers compared levels of dihydroxyphenylethyleneglycol (DOPEG), the main deaminated metabolite of NE in the central nervous system, in plasma before, during, and after 20 days of lithium treatment. We administered lithium carbonate during 20 days to seven volunteers (five men and two women aged 30 to 40 years) in good health from whom informed consent was obtained. Lithium was administered at 9 AM . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?